FDA issued a Warning Letter to Sato Pharmaceutical Co., Ltd. on 2/2/2017 as a result of this inspection.
483 Sato Pharmaceutical Feb 2016
483 Sato Pharmaceutical Feb 2016Samantha Bradley FDA$119.00 - Available Now
FDA investigators audited the Sato Pharmaceutical - Hachioji, Japan facility and issued inspectional observations (via FDA 483) on 12 Feb 2016.
Add To Cart
- Category: Human Drugs
- Inspection end: 12 Feb 2016
- Location: Hachioji, Japan
- FEI: 3004055563